封面
市場調查報告書
商品編碼
2019394

全球造影劑注射器市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Contrast Injector Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 168 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年,造影劑注射器市場規模將達到 17.4668 億美元,高於 2025 年的 10.321 億美元,預計從 2026 年到 2034 年的複合年成長率將達到 6.02%。

由於對先進造影檢查的需求不斷成長,全球造影劑注射器市場正經歷顯著成長。造影劑注射器對於增強電腦斷層掃描、MRI和血管造影術等成像技術中內部結構的可見度至關重要。慢性疾病盛行率的上升以及對精準診斷日益成長的需求是推動市場擴張的主要因素。

關鍵成長要素包括影像系統的技術進步和微創診斷方法的日益普及。由於其更高的準確性、安全性和效率,自動造影劑注射器在現代醫療環境中需求強勁。此外,人口老化和醫療保健成本的不斷上漲也推動了對影像解決方案的需求成長。

由於雙頭輸液裝置的創新以及與影像系統的整合,預計未來市場將持續成長。隨著醫療基礎設施的擴展,新興市場可能帶來巨大的成長機會。然而,高成本和監管方面的挑戰可能會限制某些地區的普及。持續的技術進步預計仍將是市場成長的關鍵驅動力。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球造影劑注射器市場:依產品分類

  • 市場分析、洞察與預測
  • 消耗品
  • 注射器
  • 管子
  • 其他
  • 注射系統
  • CT注射器
  • 核磁共振注射器
  • 血管造影術注射器
  • 配件

第5章 全球造影劑注射器市場:依注射器類型分類

  • 市場分析、洞察與預測
  • 單頭噴油器
  • 雙頭噴油器
  • 無針注射器

第6章 全球造影劑注射器市場:依應用分類

  • 市場分析、洞察與預測
  • 放射科
  • 介入放射學
  • 介入性心臟病學

第7章 全球造影劑注射器市場:依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院
  • 影像中心

第8章 全球造影劑注射器市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和分銷通路合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第10章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • General Electric
    • Vivid Imaging Solutions
    • Hilin Life Products Inc
    • Jodas Expoim Pvt. Ltd
    • Lantheus
    • Magnus Health
    • Taejoon Pharm
    • Spago Nanomedical AB
    • Guerbet
    • Bracco
    • Bayer AG
簡介目錄
Product Code: VMR11215162

The Contrast Injector Market size is expected to reach USD 1746.68 Million in 2034 from USD 1032.10 Million (2025) growing at a CAGR of 6.02% during 2026-2034.

The Global Contrast Injector Market is witnessing notable growth due to the increasing demand for advanced diagnostic imaging procedures. Contrast injectors are essential in imaging techniques such as CT scans, MRI, and angiography, as they enhance the visibility of internal structures. The rising prevalence of chronic diseases and the growing need for accurate diagnosis are major factors driving market expansion.

Key growth drivers include technological advancements in imaging systems and the increasing adoption of minimally invasive diagnostic procedures. Automated contrast injectors improve precision, safety, and efficiency, making them highly preferred in modern healthcare settings. Additionally, the growing aging population and increasing healthcare expenditure are contributing to the rising demand for diagnostic imaging solutions.

Looking ahead, the market is expected to grow with innovations in dual-head injectors and integration with imaging systems. Emerging economies are likely to offer significant growth opportunities due to expanding healthcare infrastructure. However, high equipment costs and regulatory challenges may limit adoption in certain regions. Continuous technological advancements will remain a key factor driving market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Consumables
  • Syringes
  • Tubes
  • Other consumables
  • Injector Systems
  • CT injectors
  • MRI injectors
  • Angiography injectors
  • Accessories

By Type of Injectors

  • Single-head Injectors
  • Dual-head Injectors
  • Syringeless Injectors

By Application

  • Radiology
  • Interventional Radiology
  • Interventional Cardiology

By End User

  • Hospitals
  • Diagnostic Imaging Centers

COMPANIES PROFILED

  • General Electric, Vivid Imaging Solutions, Hilin Life Products Inc, Jodas Expoim Pvt Ltd, Lantheus, Magnus Health, Taejoon Pharm, Spago Nanomedical AB, Guerbet, Bracco, Bayer AG
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CONTRAST INJECTOR MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Syringes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Tubes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Other consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Injector Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. CT injectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. MRI injectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. Angiography injectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.10. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CONTRAST INJECTOR MARKET: BY TYPE OF INJECTORS 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type Of Injectors
  • 5.2. Single-head Injectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Dual-head Injectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Syringeless Injectors Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CONTRAST INJECTOR MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Radiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Interventional Radiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Interventional Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CONTRAST INJECTOR MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Diagnostic Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CONTRAST INJECTOR MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Type Of Injectors
    • 8.2.3 By Application
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Type Of Injectors
    • 8.3.3 By Application
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Type Of Injectors
    • 8.4.3 By Application
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Type Of Injectors
    • 8.5.3 By Application
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Type Of Injectors
    • 8.6.3 By Application
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CONTRAST INJECTOR INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 General Electric
    • 10.2.2 Vivid Imaging Solutions
    • 10.2.3 Hilin Life Products Inc
    • 10.2.4 Jodas Expoim Pvt. Ltd
    • 10.2.5 Lantheus
    • 10.2.6 Magnus Health
    • 10.2.7 Taejoon Pharm
    • 10.2.8 Spago Nanomedical AB
    • 10.2.9 Guerbet
    • 10.2.10 Bracco
    • 10.2.11 Bayer AG